Cerecor Initiates Phase II Trial of CERC-301 to Treat Major Depressive …

Cerecor initiates Phase II trial of CERC-301 to treat major depressive …
The company's oral, selective NMDA receptor subunit 2B (NR2B) antagonist CERC-301is indicated for the adjunctive treatment of subjects with major depressive disorder (MDD) who have not adequately responded to their current therapy and report recent … Read more on Pharmaceutical Business Review

Insomnia Cure Boosts Success of Depression Treatment, Study Finds
If other ongoing studies confirm these results, it might lead to major changes in depression treatment, experts added. Such changes would represent the biggest advance in depression treatment since the antidepressant Prozac was introduced in 1987, The … Read more on U.S. News & World Report

Modafinil reduces depression's severity when taken with antidepressants
A new study has concluded that taking the drug modafinil, typically used to treat sleep disorders, in combination with antidepressants reduces the severity of depression more effectively than taking antidepressants alone. The study, a collaboration … Read more on Medical Xpress

Ketamine May Treat Depression Says Study
A drug long used for anesthesia for humans and animals has been shown to be quite successful for the treatment of clinical depression, particularly treatment-resistant depression. Historically, the drug ketamine, has been used for depression in sparse … Read more on Guardian Express

different types of treatment
treatments.